Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07571668
Effects of Robotic Hand Therapy on Hand Function and Dexterity in Cerebral PalsyRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07571668Not Yet Recruiting
Not Applicable
Effects of Robotic Hand Therapy on Hand Function and Dexterity in Cerebral PalsyRiphah International Univ...
NCT07570498
Strengthening the Parent-Child Relationship Through Urban NatureThe Chinese University of Hong Kong, ShenzhenCompletedNot Applicable
NCT07570498Completed
Not Applicable
Strengthening the Parent-Child Relationship Through Urban NatureThe Chinese University of...
NCT07571369
Stress Modulation and Dynamic BalanceKafrelsheikh UniversityNot Yet RecruitingNot Applicable
NCT07571369Not Yet Recruiting
Not Applicable
Stress Modulation and Dynamic BalanceKafrelsheikh University
NCT07571707
Effect of Lollipop on Emergence Delirium in Pediatric Patients Undergoing General AnesthesiaUdayana UniversityRecruitingNot Applicable
NCT07571707Recruiting
Not Applicable
Effect of Lollipop on Emergence Delirium in Pediatric Patients Undergoing Genera...Udayana University
NCT07569939
Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/or Viral TonsillitisUniversity Hospital, Clermont-FerrandNot Yet RecruitingNot Applicable
NCT07569939Not Yet Recruiting
Not Applicable
Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/o...University Hospital, Cler...
NCT07571681
Colchicine for Autoimmune and Subacute ThyroiditisMansoura UniversityNot Yet RecruitingPhase 2
NCT07571681Not Yet Recruiting
Phase 2
Colchicine for Autoimmune and Subacute ThyroiditisMansoura University
NCT07570069
Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy ParticipantsVertex Pharmaceuticals IncorporatedNot Yet RecruitingPhase 1
NCT07570069Not Yet Recruiting
Phase 1
Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy Participa...Vertex Pharmaceuticals In...
NCT07569380
Long-Term Outcomes After CDI: FMT Versus Antibiotic-Only TreatmentRegion VästerbottenNot Yet Recruiting
NCT07569380Not Yet Recruiting
—
Long-Term Outcomes After CDI: FMT Versus Antibiotic-Only TreatmentRegion Västerbotten
NCT07569068
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive Gastric/GEJ AdenocarcinomaRuijin HospitalRecruitingPhase 2
NCT07569068Recruiting
Phase 2
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Posit...Ruijin Hospital
NCT07571447
Cardiologist-Administered Midazolam vs. Anaesthesiologist-Assisted Propofol Sedation For Transoesophageal Echocardiography-Guided Cardioversion of Atrial FibrillationGødstrup HospitalNot Yet RecruitingPhase 4
NCT07571447Not Yet Recruiting
Phase 4
Cardiologist-Administered Midazolam vs. Anaesthesiologist-Assisted Propofol Seda...Gødstrup Hospital
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07570914
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver MetastasesTianjin Medical University Cancer Institute and HospitalNot Yet RecruitingPhase 2
NCT07570914Not Yet Recruiting
Phase 2
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitab...Tianjin Medical Universit...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07568782
Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers.Lille UniversityNot Yet Recruiting
NCT07568782Not Yet Recruiting
—
Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Im...Lille University
NCT07571109
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaNovo Nordisk A/SNot Yet RecruitingPhase 3
NCT07571109Not Yet Recruiting
Phase 3
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps...Novo Nordisk A/S
NCT07569926
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceBlue Earth DiagnosticsNot Yet RecruitingPhase 4
NCT07569926Not Yet Recruiting
Phase 4
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Managemen...Blue Earth Diagnostics
NCT07571395
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular FunctionPongrácz AdriennNot Yet Recruiting
NCT07571395Not Yet Recruiting
—
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular FunctionPongrácz Adrienn
NCT07570810
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DMShanghai Jiao Tong University School of MedicineNot Yet RecruitingNot Applicable
NCT07570810Not Yet Recruiting
Not Applicable
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD...Shanghai Jiao Tong Univer...
NCT07570836
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung DiseaseShanghai Zhongshan HospitalNot Yet RecruitingPhase 1
NCT07570836Not Yet Recruiting
Phase 1
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung DiseaseShanghai Zhongshan Hospit...
Result Breakdown
Not yet recruiting14 (70%)
Recruiting4 (20%)
Completed2 (10%)
not_applicable8 (40%)
Phase 24 (20%)
Not Specified3 (15%)
Phase 12 (10%)
Phase 42 (10%)
Phase 31 (5%)